I was talking to Chris Hayes the other day about the National Institutes of Health, probably the best return on investment for your taxpayer dollar there is in America. These GLP1s, ozempic things like this, you know, people associate with weight loss, but they're really to fight diabetes. Diabetes and heart disease, biggest killers in this country. Discovered by two scientists working at the NIH under a taxpayer funded grant. We all think Novo Nordisk came to market with these things, they commercialized it. (00:22–00:30)
CLAIM
Asserts that GLP1s and Ozempic are primarily for fighting diabetes, not just weight loss.
This is an excerpt from a raw transcript. The assertions have not been audited or verified. Tap the video to view the source footage and understand the context.
